Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma.

Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma.

http://www.wikidata.org/entity/Q36616798

about

Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances Targeting EZH2 in cancer The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma Epigenetic regulation in hepatocellular carcinoma requires long noncoding RNAs Aberrant upregulation of 14-3-3σ and EZH2 expression serves as an inferior prognostic biomarker for hepatocellular carcinoma Polycomb silencers control cell fate, development and cancer Long non-coding RNA LUCAT1 is associated with poor prognosis in human non-small lung cancer and regulates cell proliferation via epigenetically repressing p21 and p57 expression Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis.EZH2 depletion blocks the proliferation of colon cancer cells.The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells.High expression of H3K27me3 in human hepatocellular carcinomas correlates closely with vascular invasion and predicts worse prognosis in patients.Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells.Regulation of gene expression in HBV- and HCV-related hepatocellular carcinoma: integrated GWRS and GWGS analyses p53-paralog DNp73 oncogene is repressed by IFNα/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor.Concurrent activation of acetylation and tri-methylation of H3K27 in a subset of hepatocellular carcinoma with aggressive behavior Coordinated regulation of polycomb group complexes through microRNAs in cancer.EZH2 as a potential target in cancer therapy.Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16.Connections between epigenetic gene silencing and human disease.Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression H3K27me3 protein is a promising predictive biomarker of patients' survival and chemoradioresistance in human nasopharyngeal carcinoma Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma.MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma Differential proteomic alterations between localised and metastatic prostate cancer.Mutual regulation between CHD5 and EZH2 in hepatocellular carcinoma.Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas Cancer genetics of epigenetic genes.High expression of H3K27me3 is an independent predictor of worse outcome in patients with urothelial carcinoma of bladder treated with radical cystectomy Targeting EZH2 for cancer therapy: progress and perspective.Repression of E-cadherin by the polycomb group protein EZH2 in cancer EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.The relationship between the expression of USP22, BMI1, and EZH2 in hepatocellular carcinoma and their impacts on prognosis.Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives.Polycomb group protein gene silencing, non-coding RNA, stem cells, and cancer.Integrated bioinformatics analysis of chromatin regulator EZH2 in regulating mRNA and lncRNA expression by ChIP sequencing and RNA sequencing.Polycomb group proteins are key regulators of keratinocyte function Epigenetic regulation of skin: focus on the Polycomb complex

P2860

Q24170091-6B91B901-B851-4079-B89B-2FE6B3CFD732 Q26745338-C36A0699-6B9F-4C9F-8397-86D80ED31FD0 Q26769027-8EF00A5E-511F-47C1-B1F3-CE9BCC7ACB87 Q27003050-E5C857A1-E34A-4BB1-B996-852C10CB1518 Q27023524-9851FAC0-DCE5-4568-9563-F33695B5BC54 Q28084553-2DAF80F4-D7EC-4DB9-858F-3373CB83D205 Q28248070-C995922E-61E5-4FE3-BD75-88529106C965 Q29619697-20935BC9-C490-4329-A535-611FA1B94568 Q33709689-DD20BF23-CE4B-479C-8DA0-899A629FFD6B Q33710169-F0064200-1727-4B11-8A88-D97502038ED4 Q33867376-2DD140E0-76FC-4338-AEE5-30BDE3B3D6D6 Q33963796-B22D5104-3AD0-42A1-BD3C-9B4FB7823F86 Q34137728-72DD14E8-E3E0-4A12-A668-FD0F2C0CB368 Q34500720-B18E91A9-5CF4-4F43-A542-0F034594EAB1 Q34690158-D69FB068-57FC-434F-85C0-67B0764569B7 Q34769837-73D074E2-25DA-4C98-AB72-A8B126405ED0 Q35042810-086549BF-2F73-4B7B-B2D7-2E3F4BF0DE55 Q35116342-1F9EAD2A-E328-46D5-94EC-CD0183D3C4DB Q35167450-755C1F28-CA20-431D-96D5-88971F98E854 Q35222823-822596C4-3261-48ED-83ED-96815E1DD23A Q35443085-1535DE6F-A90C-4563-9BF4-259998C74B17 Q35843804-616B80D5-BD87-4A3C-8577-E67132F15DE3 Q35849140-E7A9F79B-EEFD-4C22-A4DF-1EA8182CD2D4 Q35876813-458DEE60-ACCA-485B-924A-E9D174DD1F0E Q36105152-91F71C17-F8E1-4183-82E9-1CA30E1E233B Q36394758-C1B1C29C-7F10-4C50-9931-5645B0E204F6 Q36553042-C4D0DD1D-2461-4F40-9E6B-27B50B8C1EE8 Q36562226-932206CE-7C6E-4D67-8FE6-739A3E4D0DB3 Q36780903-F79FB862-69AB-4E26-B4DE-B0E1A657ED7A Q36871595-FAB4A761-DB44-4569-93D3-9E4EF8329E28 Q37182805-CDF9FD4F-D19D-4475-9917-D9259F41D7EA Q37204063-C624E5E2-E1AD-4C1A-9C30-E4788C3881C2 Q37212534-CAD4471F-7589-4A78-B49D-84CDAAFA2BAC Q37392656-034722A4-A05E-47A3-B99D-81957DAF076C Q37446527-2BA60183-2F47-4083-AF2D-3F1896010CC8 Q37581334-016F5D86-F3DE-432F-B819-2E288F1C15B6 Q37629613-FA72A789-D575-4250-AC81-1CC54FB83891 Q37697207-C02381BF-2ACF-4796-ABB1-FEC4FF38547E Q37810463-609D3492-5444-4C24-BBB5-1B4F8EC9522B Q37982255-9FC3D2C0-EAE6-4EE4-97C5-68DE7937B99A

P2860

Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma.

http://www.wikidata.org/entity/Q36616798

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Clinicopathological significan ...... with hepatocellular carcinoma.

@ast

Clinicopathological significan ...... with hepatocellular carcinoma.

@en

type

label

Clinicopathological significan ...... with hepatocellular carcinoma.

@ast

Clinicopathological significan ...... with hepatocellular carcinoma.

@en

prefLabel

Clinicopathological significan ...... with hepatocellular carcinoma.

@ast

Clinicopathological significan ...... with hepatocellular carcinoma.

@en

P1433

Q36616798-33702C08-C3D1-4E39-88F7-3B6D5E1DDAAD

P1476

Q36616798-9089BD2D-9F55-4182-9BD8-92BB95CB690F

P2093

Q36616798-0A410BD9-9E35-424D-A784-D6BD493D73EC

Q36616798-1F212360-EA97-4308-8D74-DD48A0605BA4

Q36616798-6C3C4AB5-B91D-4BF9-9DBE-AC982A1BEC1D

Q36616798-8FA6DFA8-291E-4B63-949E-319559C56D06

Q36616798-92895E27-ADD3-43BE-961F-B4991823D84B

Q36616798-CBEFE0B9-3338-4A32-A78A-0517C1D353BB

Q36616798-D02DC1BF-5596-4D91-9936-F170ABF1C401

Q36616798-DF20B665-B2C6-4D84-BB1A-E07F4530DB35

Q36616798-EC4AFD00-C4E0-4F03-A460-F2FA13C7FFA6

Q36616798-EFC94FF8-032B-4A17-B595-03B51CE4B340

P2860

Q36616798-0410852E-DC6C-4032-BFDB-BF26AF674F08

Q36616798-0D92D583-997D-451E-BCF9-44EAA6F63DD6

Q36616798-0DEA9F46-4C14-4AF1-AA69-40F1C9692E1B

Q36616798-13FDD928-057E-4289-BCD9-24D1E79196EE

Q36616798-40A0E152-7D55-4E45-8C3F-3D23AE0A38B7

Q36616798-495EEBCA-EF2D-4B15-98DD-CE38DFBEBA7B

Q36616798-54899F9A-7337-4233-BF36-066756F7A925

Q36616798-5587FC29-D8EF-469C-853B-5382299301B9

Q36616798-5745C692-8BF4-4C16-8D51-66AB437E6B14

Q36616798-63A73BA4-FE06-4193-91DE-2EFF3A20E42D

P2888

Q36616798-F090FD74-0403-45C4-9F0F-73112C75D294

P304

Q36616798-C374B0F3-42CF-49A2-B077-19B5AD8D1C77

P31

Q36616798-67CF8EB4-1776-49D7-B06D-560C30AC61FD

P356

Q36616798-BDC49145-54B2-472D-8060-6351914A0D27

P407

Q36616798-8ECAF234-D204-4D1F-991C-9DB8CE2A3805

P433

Q36616798-40E9AC1E-4EDE-4DA0-8B7B-BEFF9C9A33C3

P478

Q36616798-8E827991-BAD1-43DC-9B69-6BE6200A310A

P577

Q36616798-7FA503E7-7739-4AAF-A3B8-7A7228EFFC92

P5875

Q36616798-0ECFA7D0-F9ED-4E20-8F68-CF621BB60A65

P698

Q36616798-37535849-0099-4CC5-AB86-15B8AE849509

P932

Q36616798-8D986E13-529F-49E6-A6A5-DF8EC2FDC027

P356

P1433

British Journal of Cancer

P1476

Clinicopathological significan ...... with hepatocellular carcinoma.

@en

P2093

H Fujita

http://www.w3.org/2001/XMLSchema#string

H Inoue

http://www.w3.org/2001/XMLSchema#string

H Nagahara

http://www.w3.org/2001/XMLSchema#string

K Mimori

http://www.w3.org/2001/XMLSchema#string

K Ogawa

http://www.w3.org/2001/XMLSchema#string

K Shirouzu

http://www.w3.org/2001/XMLSchema#string

M Mori

http://www.w3.org/2001/XMLSchema#string

S Wakiyama

http://www.w3.org/2001/XMLSchema#string

T Sudo

http://www.w3.org/2001/XMLSchema#string

T Utsunomiya

http://www.w3.org/2001/XMLSchema#string

P2860

Mammalian homologues of the Polycomb-group gene Enhancer of zeste mediate gene silencing in Drosophila heterochromatin and at S. cerevisiae telomeres

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation

The polycomb group protein EZH2 is involved in progression of prostate cancer

The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus

Polycomb group protein complexes: do different complexes regulate distinct target genes?

EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer

The EZH2 polycomb transcriptional repressor--a marker or mover of metastatic prostate cancer?

Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease.

Clinical significance of elongation factor-1 delta mRNA expression in oesophageal carcinoma.

P2888

P304

1754-1758

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6602531

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7882100

http://www.w3.org/2001/XMLSchema#string

P698

15856046

http://www.w3.org/2001/XMLSchema#string

P932

2362028

http://www.w3.org/2001/XMLSchema#string